ArticleJournal of general internal medicine2026
Outpatient Follow-up Care for Diabetes Following Discharge from the Emergency Department.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundOver 16 million adult patients visit the emergency department (ED) for diabetes-related conditions yearly. Although most patients are discharged from the ED without requiring hospitalization, it is unknown how often these individuals obtain outpatient follow-up care for medication adjustment, symptom monitoring, and counseling.
objectiveTo describe incidence, timing, and patient characteristics associated with outpatient follow-up after discharge from the ED for diabetes-related encounters in a national cohort.
designRetrospective cohort study.
participantsAdults with commercial insurance or Medicare Advantage who were discharged from the ED with principal encounter diagnosis related to type 1 or type 2 diabetes mellitus. MAIN MEASURES: The primary outcome was an outpatient visit for diabetes-related care within 30 days of ED discharge. Return ED visit prior to outpatient follow-up was treated as a competing outcome. Multivariable competing risk regression models were used to estimate adjusted hazard ratios (aHRs) for patient characteristics associated with obtaining follow-up, including demographic, socioeconomic, and clinical factors. KEY
resultsOf the 131,881 patients included in this study (mean age, 63.0 years; 51.6% female), 60,798 (46.1%) obtained outpatient follow-up within 30 days, while 17,099 (13.0%) returned to the ED prior to follow-up. Follow-up rates increased modestly over the study period, from 44% in 2016 to 49% in 2022. In adjusted analyses, older age, commercial insurance, and greater prior outpatient care engagement were associated with higher likelihood of follow-up. Patients with Non-Hispanic Black race, Medicare low-income subsidy, greater comorbidity burden, and diagnosis of type 1 diabetes had lower likelihood of follow-up.
conclusionsIn this study, fewer than half of adults discharged from the ED after diabetes-related encounters obtained outpatient follow-up within 30 days. These findings highlight an unrecognized gap in care continuity for patients with diabetes and should inform future interventions to improve care transitions for patients with acute illness related to diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.